Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Scientific Reports

ISSN 2045-2322

308 papers in the library · 7,149 citations · publishing 2009-2026

Papers

The psychological correlates of distinct neural states occurring during wakeful rest

Scientific Reports December 3, 2020 Theodoros Karapanagiotidis, Diego Vidaurre, Andrew J. Quinn et al. 82 citations

When people are not engaged in an explicit task, they experience a variety of self-generated thoughts, such as planning or reminiscing. Using machine learning to analyze brain activity from resting-state fMRI scans, researchers identified distinct neural states that recur over time. Two of these states predicted different patterns of thinking. One neural state, resembling activity seen during demanding tasks, was linked to problem-solving about the future. Another state, associated with less demanding conditions, was tied to intrusive thoughts about the past. These two states fell at opposite ends of a brain hierarchy related to cognitive demand. The findings show that tracking moment-to-moment changes in brain function can help classify self-generated mental states and that these states align with the brain's response to cognitive tasks.

Cannabis and tolerance: acute drug impairment as a function of cannabis use history

Scientific Reports May 26, 2016 Johannes G. Ramaekers, J. H. van Wel, Desirée Spronk et al. 81 citations

Acute cannabis intoxication impairs executive function, impulse control, attention, and psychomotor function, and increases subjective intoxication, regardless of how frequently a person uses cannabis. In a study of 122 drug users with cannabis use histories ranging from infrequent to daily, cannabis (300 μg/kg THC) produced these deficits compared to placebo, while cocaine (300 mg) improved psychomotor function and attention but impaired impulse control. The absence of tolerance to cannabis's neurocognitive effects suggests that frequent use and intoxication can interfere with performance in daily environments such as school, work, or traffic.

Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers

Scientific Reports November 18, 2021 Joseph M. Rootman, Pamela Kryskow, Kalin Harvey et al. 78 citations

Among self-selected users of a mobile app, people who microdose psychedelics (mostly psilocybin, 85%) were similar demographically to non-microdosers but more often reported a history of mental health concerns. Within that group, microdosers had lower levels of depression, anxiety, and stress across genders. Health and wellness motives were the most common reasons for microdosing, especially among women and those with mental health concerns. The findings highlight a need for rigorous longitudinal research on microdosing's mental health effects.

Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey

Scientific Reports November 3, 2017 Will Lawn, Jaime E. C. Hallak, José Alexandre S. Crippa et al. 78 citations

Ayahuasca users reported greater well-being than both classic psychedelic users and non-psychedelic drug users, and less problematic drinking than classic psychedelic users, though both psychedelic groups reported more problematic drinking than non-psychedelic users. Ayahuasca's acute subjective effects typically lasted six hours, peaking one hour after consumption. These findings come from a large online survey of nearly 97,000 respondents, including 527 ayahuasca users. The authors call for longitudinal studies and randomized trials to further investigate ayahuasca's effects on well-being and alcohol use.

Frequent lucid dreaming associated with increased functional connectivity between frontopolar cortex and temporoparietal association areas

Scientific Reports December 6, 2018 Benjamin Baird, Anna Castelnovo, Olivia Gosseries et al. 74 citations

People who have frequent lucid dreams—three or more per week—show stronger functional connections between the left anterior prefrontal cortex and several brain regions, including the angular gyrus, middle temporal gyrus, and inferior frontal gyrus, compared to people who rarely or never lucid dream. These connections involve areas that are normally less active during sleep. No differences in brain structure were found. The findings suggest that frequent lucid dreaming is linked to how certain brain networks communicate, not to structural differences.

Alterations in the inflammatory cytokines and brain-derived neurotrophic factor contribute to depression-like phenotype after spared nerve injury: improvement by ketamine

Scientific Reports June 5, 2017 Ze-Min Xie, Xingming Wang, Ning Xu et al. 69 citations

Rats with neuropathic pain that also developed depression-like behaviors had higher levels of pro-inflammatory cytokines (interleukin-1β and interleukin-6) and an imbalance between pro- and anti-inflammatory cytokines, along with lower levels of brain-derived neurotrophic factor in the prefrontal cortex, compared to rats without depression-like behaviors and sham-operated controls. A single dose of ketamine reversed both the depression-like behaviors and the elevated serum levels of IL-1β and IL-6. These findings suggest that changes in inflammatory cytokines and BDNF may underlie depression caused by neuropathic pain, and that serum cytokines could serve as biomarkers for ketamine's antidepressant effects.

Reduced age-associated brain changes in expert meditators: a multimodal neuroimaging pilot study

Scientific Reports August 25, 2017 Gaël Chételat, Florence Mezenge, Clémence Tomadesso et al. 67 citations

Aging typically shrinks brain volume and lowers glucose metabolism, with stress and poor sleep accelerating these changes. In a pilot study comparing 6 elderly expert meditators with 67 elderly controls, the meditators showed greater gray matter volume and/or FDG metabolism in several brain regions: the ventromedial prefrontal and anterior cingulate cortex, insula, temporo-parietal junction, and posterior cingulate cortex/precuneus. These same regions were most affected by age in a larger control group of 186 people aged 20 to 87. The differences persisted after adjusting for lifestyle factors and education. The findings suggest that lifelong meditation might reduce age-related brain decline, but larger and longitudinal studies are needed.

Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience.

Scientific Reports May 24, 2022 David Wyndham Lawrence, Robin Carhart-Harris, Roland R. Griffiths et al. 64 citations

An analysis of over 3,700 naturalistic experiences with inhaled N,N-DMT posted to Reddit over a decade reveals common themes. Somatic effects like body sensations (37.5%) and auditory ringing (15.4%) were frequent, while visualizations often involved fractals, shapes, and vivid colors. Entity encounters occurred in 45.5% of experiences, most commonly with a feminine phenotype, deities, aliens, and creature-based beings. Interactions were predominantly positive or pedagogical. Descriptions of alternate dimensions, rooms including a 'waiting room,' and tunnels were common. Mystical and ego-dissolution features were frequent, along with rewarding aspects like reduced fear of death. Challenging responses were less common.

Improving stress management, anxiety, and mental well-being in medical students through an online Mindfulness-Based Intervention: a randomized study.

Scientific Reports May 22, 2023 Teresa Fazia, Francesco Bubbico, Andrea Nova et al. 62 citations

A mindfulness-based program combining meditation, dietary advice, and yoga reduced stress and improved well-being, emotional regulation, resilience, and attention among medical students. In a randomized trial with 362 Italian medical students, those who participated in the 10-session intervention showed significantly lower perceived stress, less mind-wandering, and better emotional regulation compared to controls. The program also enhanced mental well-being, resilience, and attentional control, while reducing overall distress. These results suggest that such integrative interventions can help mitigate the psychological strain common in medical education.

RETRACTED ARTICLE: A mechanistic model of the neural entropy increase elicited by psychedelic drugs

Scientific Reports October 20, 2020 Rubén Herzog, Pedro A. M. Mediano, Fernando E. Rosas et al. 60 citations

Psychedelic drugs such as lysergic acid diethylamide, which activate the serotonin 2A receptor, produce profound changes in consciousness and increase entropy in spontaneous neural activity. This study provides the first model-based explanation for that entropy increase by extending a whole-brain model of serotonergic neuromodulation. The model reproduced the overall entropy rise seen in previous experiments. Entropy changes were not uniform: some brain regions showed increased entropy while others showed decreases, indicating a topographical reconfiguration driven by receptor activation. At the whole-brain level, this reconfiguration was not well explained by receptor density but was closely related to the brain's anatomical connectivity topology.

Consciousness and cortical responsiveness: a within-state study during non-rapid eye movement sleep

Scientific Reports August 5, 2016 Jaakko O. Nieminen, Olivia Gosseries, Marcello Massimini et al. 60 citations

During non-rapid eye movement (NREM) sleep, the brain's response to transcranial magnetic stimulation (TMS) differs depending on whether the person is conscious (dreaming) or not. When subjects reported no conscious experience upon awakening, TMS evoked a larger negative deflection and a shorter phase-locked response compared to when they reported a dream. The amplitude of the negative deflection—a hallmark of neuronal bistability—was inversely correlated with the length of the dream report. These findings suggest that variations in the level of consciousness within the same physiological state are associated with changes in underlying cortical bistability.

Fragile temporal prediction in patients with schizophrenia is related to minimal self disorders

Scientific Reports August 15, 2017 B. Martin, N. Franck, M. Cermolacce et al. 58 citations

People with schizophrenia struggle to predict when events will happen based on elapsed time, and this difficulty relates to disturbances in the sense of self. In a study of 28 patients and 24 matched controls, participants viewed a visual cue that either predicted or did not predict when a target would appear (after 400 ms or 1000 ms). Both groups responded faster to targets after longer intervals due to the natural predictability of time passing (the hazard function). However, patients with high scores on the EASE scale for self-awareness and presence showed no benefit from this temporal predictability, while those with low scores did.

Fully automated head-twitch detection system for the study of 5-HT2A receptor pharmacology in vivo

Scientific Reports October 3, 2019 Mario de la Fuente Revenga, Jong M. Shin, Hiba Vohra et al. 57 citations

A fully automated system detects head-twitch behavior (HTR) in mice, a behavioral marker of psychedelic drug action at the serotonin 5-HT2A receptor. The system was validated using the psychedelic DOI in mice lacking the 5-HT2A receptor and by evaluating false-positive and false-negative events. Automation enabled efficient time-course studies. Pharmacological interactions between the 5-HT2A receptor and metabotropic glutamate receptor 2 (mGluR2) were explored: the mGluR2/3 antagonist LY341495 potentiated DOI-induced HTR, while the mGluR2/3 agonist LY404039 blocked it. This system can accelerate understanding of 5-HT2A receptor pharmacology and its behavioral outputs in rodents.

Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial.

Scientific Reports April 17, 2024 Jordan Sloshower, Richard J. Zeifman, Jeffrey Guss et al. 56 citations

Psilocybin-assisted therapy improves psychological flexibility, mindfulness, and values-congruent living in people with moderate to severe major depressive disorder, and these improvements are strongly linked to reductions in depression severity. In an exploratory placebo-controlled study, participants received placebo then psilocybin (0.3 mg/kg) four weeks later, with dosing sessions embedded in Acceptance and Commitment Therapy. Psychological flexibility, several facets of mindfulness, and values-congruent living significantly improved after psilocybin and were maintained through week 16. The findings suggest that increasing psychological flexibility may be a key mechanism underlying psilocybin's therapeutic effects.

Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample

Scientific Reports April 7, 2022 Grant Jones, Jocelyn A. Ricard, Joshua Lipson et al. 56 citations

People who have used psilocybin at some point in their lives have 30% lower odds of having opioid use disorder, based on data from a large U.S. national survey. No other classic psychedelic substances—such as LSD, peyote, or mescaline—showed a similar association. Psilocybin use was also linked to lower odds of meeting seven of the 11 diagnostic criteria for opioid use disorder. These findings suggest psilocybin may hold promise as a treatment, but clinical trials are needed to establish causality.

Associations between lifetime classic psychedelic use and cardiometabolic diseases

Scientific Reports July 13, 2021 Otto Simonsson, Walter Osika, Robin Carhart-Harris et al. 54 citations

Lifetime use of classic psychedelics is associated with lower odds of heart disease and diabetes. Analyzing data from the National Survey on Drug Use and Health (2005–2014), people who had ever tried a classic psychedelic had 23% lower odds of past-year heart disease and 12% lower odds of past-year diabetes. The associations persisted after adjusting for other factors. The authors suggest classic psychedelic use might benefit cardiometabolic health but call for more research on causal pathways.

Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls

Scientific Reports June 30, 2022 Joseph M. Rootman, Maggie Kiraga, Pamela Kryskow et al. 53 citations

A naturalistic observational study followed 953 people who microdosed psilocybin (taking small, non-hallucinogenic doses of psychedelic mushrooms) and 180 non-microdosers for about 30 days. Small to medium improvements in mood and mental health were observed among microdosers, consistent across gender, age, and pre-existing mental health concerns. Older adults showed specific improvements in psychomotor performance. Combining psilocybin with lion's mane mushrooms and niacin did not affect mood or mental health changes, but among older microdosers, this combination was linked to greater psychomotor improvements than psilocybin alone or with lion's mane. These findings add controlled evidence to the growing research on psychedelic microdosing.

The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain

Scientific Reports October 2, 2020 Manoj K. Doss, Darrick G. May, Matthew W. Johnson et al. 52 citations

Salvinorin A, a κ-opioid receptor agonist and dissociative hallucinogen found in Salvia divinorum, alters human brain functional connectivity in ways similar to other hallucinogens. In a placebo-controlled, within-subject fMRI study, inhaled Salvinorin A tended to decrease functional connectivity within brain networks while increasing connectivity between networks, most notably attenuating the default mode network during peak effects. It reduced brainwide dynamic functional connectivity but increased brainwide entropic functional connectivity, though only the reduction survived statistical correction. Connectome-based classification models trained on dynamic connectivity accurately identified Salvinorin A scans, especially when using default mode network interactions. These findings suggest shared neural mechanisms across hallucinogen types.

A whole-brain model of the neural entropy increase elicited by psychedelic drugs.

Scientific Reports April 17, 2023 Rubén Herzog, Pedro A. M. Mediano, Fernando E. Rosas et al. 51 citations

Psychedelic drugs such as LSD, which activate the serotonin 2A receptor, produce profound changes in consciousness and are linked to increased entropy in spontaneous brain activity. This study provides the first model-based explanation for that entropy increase by extending a whole-brain model of serotonin neuromodulation. The model reproduced the overall rise in neural entropy seen in prior experiments. Entropy increased across all brain regions, with the largest effects in visuo-occipital areas. At the whole-brain level, this reconfiguration was not well explained by the density of serotonin 2A receptors but was closely related to the topological properties of the brain's anatomical connectivity.

Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study

Scientific Reports February 5, 2024 Alistair Niemeijer, Erwin Krediet, Jeanine Kamphuis et al. 50 citations

Patients with treatment-resistant depression who received psilocybin in a clinical trial described challenges with trust-building and expectation management, the need to navigate intense experiences often guided by music, and a desire for a more comprehensive treatment including multiple psilocybin sessions and sustained therapy. Distrust in mental healthcare generally, but trust in study therapists, was a key subtheme. The findings suggest that optimizing psilocybin treatment for this population requires individualized preparation, investment in trust-building, additional sessions, and access to ongoing psychotherapy with trusted therapists.

Genome-wide association study and polygenic risk score analysis of esketamine treatment response

Scientific Reports July 28, 2020 Qingqin S. Li, Ewa Wajs, Rachel Ochs-Ross et al. 49 citations

A genome-wide association study in 527 people of European ancestry with major depressive disorder identified a significant genetic locus in the IRAK3 gene and a significant gene-level association in NME7 linked to the antidepressant efficacy of esketamine nasal spray, measured as percentage change in symptom severity. Polygenic risk score analysis showed the strongest association with esketamine efficacy came from genetic loading for depressive symptoms, though this did not reach study-wide significance. Suggestive signals were enriched in pathways related to neuronal and synaptic function, immune signaling, and glucocorticoid receptor/stress response.

The Effect of Mindfulness Meditation on Impulsivity and its Neurobiological Correlates in Healthy Adults

Scientific Reports August 19, 2019 Cole Korponay, Daniela Dentico, Tammi R. A. Kral et al. 49 citations

An eight-week mindfulness intervention did not reduce impulsivity on the go/no-go task or Barratt Impulsiveness Scale (BIS-11), nor produce changes in neural correlates such as frontostriatal gray matter, functional connectivity, or dopamine levels compared to active or wait-list control groups. Long-term meditators (LTMs) did not differ from meditation-naïve participants (MNPs) on the go/no-go task, but LTMs self-reported lower attentional impulsivity and higher motor and non-planning impulsivity on the BIS-11. LTMs had less striatal gray matter, greater cortico-striatal-thalamic functional connectivity, and lower spontaneous eye-blink rate than MNPs. Total lifetime practice hours did not significantly relate to impulsivity or neurobiological metrics, suggesting pre-existing differences may account for group differences.

Evoked Alpha Power is Reduced in Disconnected Consciousness During Sleep and Anesthesia

Scientific Reports November 5, 2018 Matthieu Darracq, Chadd M. Funk, Daniel Polyakov et al. 49 citations

Sleep and anesthesia alter conscious experience, which can be absent (unconsciousness) or take the form of dreaming where sensory stimuli are not incorporated (disconnected consciousness). Using transcranial magnetic stimulation-electroencephalography over parietal regions, evoked alpha power (8-12 Hz) decreased during disconnected consciousness in rapid eye movement sleep and ketamine anesthesia compared to wakefulness. In unconscious states of propofol anesthesia and non-rapid eye movement sleep, evoked low-gamma power (30-40 Hz) decreased compared to wakefulness or disconnected consciousness. These findings, confirmed with dream reports from serial awakenings, suggest suppression of evoked alpha activity may mark sensory disconnection.

Distinct individual differences in default mode network connectivity relate to off-task thought and text memory during reading

Scientific Reports November 7, 2019 Meichao Zhang, Nicola Savill, Daniel S. Margulies et al. 48 citations

People often find their thoughts drifting away from the text they are reading, a tendency known as mind-wandering, which impairs comprehension and memory for the text. Using fMRI, the study found that individuals with poorer memory for texts show reduced activity in the left middle temporal gyrus in response to written input. This region sits at the intersection of the default mode, dorsal attention, and frontoparietal networks. In a resting-state analysis, stronger connectivity within the default mode network was associated with better text memory, while greater decoupling between the default mode network and medial visual regions was linked to more frequent mind-wandering. These results suggest that intrinsic brain network connectivity influences how attention stays engaged with reading.

Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA and psilocybin) and psychological distress and suicidality.

Scientific Reports October 10, 2022 Grant Jones, Matthew K. Nock 46 citations

Lifetime use of MDMA or psilocybin is associated with lower odds of psychological distress and suicidality among White individuals, but these protective associations are far fewer for racial and ethnic minorities. Analyzing data from over 484,000 participants in the National Survey on Drug Use and Health (2008–2019), race and ethnicity significantly moderated the links between psychedelic use and mental health outcomes. The findings highlight the need for further research on how identity factors such as race, ethnicity, socioeconomic status, and sexual/gender minority status influence the effects of psychedelic substances.